IIM
DYN icon

INTECH Investment Management’s Dyne Therapeutics DYN Stock Holding History

INTECH Investment Management’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$537K Sell
29,600
-14,688
-33% -$253K 0.01% 1305
2025
Q4 		$866K Sell
44,288
-8,762
-17% -$166K 0.01% 1209
2025
Q3 		$671K Sell
53,050
-12,976
-20% -$148K 0.01% 1409
2025
Q2 		$629K Sell
66,026
-11,325
-15% -$125K 0.01% 1468
2025
Q1 		$809K Buy
77,351
+43,375
+128% +$620K 0.01% 1330
2024
Q4 		$800K Buy
33,976
+8,162
+32% +$241K 0.01% 1286
2024
Q3 		$927K Buy
+25,814
New +$1.03M 0.01% 858

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

INTECH Investment Management's DYN Position: Q1 2026 in Review

INTECH Investment Management reduced its Dyne Therapeutics (DYN) stake by 33% in Q1 2026, selling an estimated $253K and leaving 29,600 shares worth $537K. The position accounts for 0.01% of the portfolio, ranked #1305.

INTECH Investment Management first reported a position in DYN in Q3 2024 and has held it in 7 quarters since. The position peaked at $927K in Q3 2024. 227 funds tracked by Wall St. Rank hold DYN as of Q1 2026.

  • INTECH Investment Management held 29,600 shares of Dyne Therapeutics worth $537K as of Q1 2026.
  • INTECH Investment Management sold 14,688 Dyne Therapeutics shares in Q1 2026, an estimated $253K.
  • Dyne Therapeutics made up 0.01% of INTECH Investment Management's portfolio in Q1 2026, its #1305 holding.
  • INTECH Investment Management first reported a position in Dyne Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • INTECH Investment Management's Dyne Therapeutics position peaked at $927K in Q3 2024.
  • 227 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q1 2026.

Based on INTECH Investment Management's 13F filing for Q1 2026, filed 8 May 2026.